Oncology Grants
In continuation of CHF’s strong support of canine cancer research, the Oncology Research Program Area remains committed to innovative research that will aid in the discovery of advanced diagnostic technology and therapeutic target identification.
To make sense of the complexity of cancer, new approaches are needed to provide comprehensive characterization of tumors and other canine cancers. These approaches will likely require broad bioinformatic analyses, high throughput methodologies and systems biology tools.
Active Grants:
Previously Awarded Grants:
| 00811-A | Gene Expression Profiling of Canine Lymphocytic Leukemia |
| 366 | Molecular Control of COX-2 Expression and Regulation of Prostaglandin Transport in Canine Mammary Tumors |
| 249 | Genomics of Canine Brain Neoplasia |
| 00022101T | Development of Anti-Canine Il-2R? Antibodies Using CpG Oligodeoxynucleotide Vaccination |
| 00664-A | Exploration of Alternative Samples for Prognostic Assay of Canine Cancers: Getting the Most Out of Existing Samples and Testing New Ones Collected Without Surgery |
| 2667 | Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas |
| 00675-A | Evaluation of the Safety of Cisplatin/COX-2 Inhibitor Treatment for Canine Cancer |
| 0002254B | Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma |
| 00339-A | Expression of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) in Canine Oral Malignant Melanoma |
| 0002254A | Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma |
| 00205-A | Relationship of Clinical Stage and Ki-67 Expression to Recurrence Following Radiotherapy of Canine Intranasal Neoplasia |
| 0002214T | Identification of a 5-10Mb BAC Set as a Cytogenetic Resource and for the Development of an Ordered CGH Microarray for Cancer Studies in the Dog |
| 2222 | Molecular Control of Prostaglandin Synthesis in Canine Mammary Tumors |
| 2105 | Characterization of Host and Environmental Risk Factors for Urinary Bladder Cancer in a High Risk Breed (the Scottish Terrier) |
| 2010 | Dissecting the Biology and Genetics of c-Kit Mutations in Canine Mast Cell Tumors |
| 2035 | Transferrin Receptor Expression by Canine Brain Tumors |
| 1817 | Genetics of Malignant Histiocytomas in the Flat-Coated Retriever |
| 0001626T | Significance of Tumor Suppressor Genes in Canine Cancer |
| 1456 | Immunohistochemical and Mutational Analysis of p53 in Archival Benign and Malignant Tumors of Flat-Coated Retrievers |
The AKC Canine Health Foundation funds research in 23 different Research Program Areas for the health of all dogs. These program areas enable the Foundation to create depth in our research portfolio and help us to be responsive to the health concerns of our constituents.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
